You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Rubicon Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?

RUBICON has sixty-seven approved drugs.



Summary for Rubicon
US Patents:0
Tradenames:55
Ingredients:55
NDAs:67

Drugs and US Patents for Rubicon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 215376-001 May 1, 2023 AB RX No No ⤷  Try for Free ⤷  Try for Free
Rubicon ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 215723-003 Jul 8, 2022 AB RX No No ⤷  Try for Free ⤷  Try for Free
Rubicon OXCARBAZEPINE oxcarbazepine TABLET;ORAL 077747-002 Apr 9, 2008 AB RX No No ⤷  Try for Free ⤷  Try for Free
Rubicon METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-002 Oct 28, 2014 AB RX No No ⤷  Try for Free ⤷  Try for Free
Rubicon BACLOFEN baclofen SOLUTION;ORAL 214445-001 Dec 6, 2024 RX No No ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.